CDK4/6 Inhibitors: What Is the Best Cocktail?

被引：17
|
作者：
Malumbres, Marcos [1 ,2 ]
机构：
[1] Spanish Natl Canc Res Ctr CNIO, Cell Div, Madrid, Spain
[2] Spanish Natl Canc Res Ctr CNIO, Canc Grp, Madrid, Spain
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 01期
关键词：
D O I：
10.1158/1078-0432.CCR-18-2177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CDK4/6 inhibitors have shown great potential in the new armamentarium against cancer. However, their effect as single agents is limited, and the hopes are on new combinatory strategies. Recent data suggest that inhibiting mTOR may significantly cooperate with cell- cycle arrest in a variety of cancers.
引用
收藏
页码：6 / 8
页数：3
相关论文
共 50 条
  • [1] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [2] CDK4/6 inhibitors in advanced breast cancer, what is beyond?
    Mohammed, Amrallah A.
    Rashied, Hanaa
    Elsayed, Fifi Mostafa
    ONCOLOGY REVIEWS, 2019, 13 (02) : 125 - 133
  • [3] CDK4/6 inhibitors prolong OS
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) : 722 - 722
  • [4] CDK4/6 inhibitors: The Devil is in the Detail
    Magge, Tara
    Rajendran, Sneha
    Brufsky, Adam M.
    Foldi, Julia
    CURRENT ONCOLOGY REPORTS, 2024, 26 (06) : 665 - 678
  • [5] Development and strategies of CDK4/6 inhibitors
    Chen, Pingping
    Xu, Yinqiu
    Li, Xuanyi
    Yao, Hequan
    Lin, Kejiang
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (02) : 127 - 145
  • [6] Immunomodulatory effects of CDK4/6 inhibitors
    Zhang, Shumeng
    Xu, Qiaomai
    Sun, Wenjia
    Zhou, Jianya
    Zhou, Jianying
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (04):
  • [7] CDK4/6 inhibitors prolong OS
    David Killock
    Nature Reviews Clinical Oncology, 2019, 16 : 722 - 722
  • [8] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [9] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [10] Recent Progress in CDK4/6 Inhibitors and PROTACs
    Wang, Hao
    Ba, Jianfei
    Kang, Yue
    Gong, Zeqiao
    Liang, Tingting
    Zhang, Yahong
    Qi, Jianguo
    Wang, Jianhong
    MOLECULES, 2023, 28 (24):
12345